Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne

NCT00833183 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2009-01-30

No results posted yet for this study

Summary

A study of safety and efficacy of topical methyaminlevulinate 80mg/g with and without occlusion followed by red light exposure in subjects with facial acne.

Conditions

Interventions

DRUG

MAL

80 mg/g cream one administration with incubation for 90 minutes

Sponsors & Collaborators

  • Photocure

    lead INDUSTRY

Principal Investigators

  • Robert Bissonnette, MD MSC FRCPC · Innovaderm Research Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00833183 on ClinicalTrials.gov